首页> 美国政府科技报告 >Comparative mutagenesis of human cells in vitro and in vivo. Final progress report, 1 November 1995--31 October 1996
【24h】

Comparative mutagenesis of human cells in vitro and in vivo. Final progress report, 1 November 1995--31 October 1996

机译:体外和体内人体细胞的比较诱变。最后进度报告,1995年11月1日至1996年10月31日

获取原文

摘要

By combining the separation technology of CDCE (constant denaturing capillary electrophoresis) with high fidelity DNA amplification the authors devised a reliable means to measure mutant fractions of any and all point mutations in human cell or tissue mitochondrial DNA arising at mutant fractions at or above 10 (sup (minus)6). Measurements in nuclear genes are more difficult than in mitochondrial genes. First, the average mutant fractions per base pair in middle-aged human T cells' hprt gene are about 10(sup (minus)8) which is much lower than the approximately 3 (times) 10(sup (minus)6) they have found for mitochondrial point mutations in several human tissues. To see point mutational nuclear hotspots they need an analytical procedure which is reliable at mutant fractions of 10(sup (minus)7) and higher. Fortunately, they are close to that goal. At this writing, reconstruction experiments with human cells indicate they have achieved a sensitivity at least as low as 5 (times) 10(sup (minus)7) so they are optimistic that they can reach the required criterion.

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号